Login to your Case File
 
Untitled Document
References

Stem Cell Therapy 

[1] US National Institutes of Health: http://stemcells. nih.gov/info/basics/basics1
[2] US National Institutes of Health: http://stemcells.nih.gov/info/glossary
[3] US National Institutes of Health: http://stemcells.nih.gov/info/scireport/chapter4.asp
 

Cardiovascular

[1] American Heart Association: http://wwwcamericanheart.org/presenter.jhtml?identifier=4720
[2] Mayo Clinic: http://www.mayoclinic.org/quality/ami.html
[3] Cleveland Clinic: http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/cardiology/acute-myocardial-infarction/#s0080
[4] Mayo Clinic: http://www.mayoclinic.com/health/dilated-cardiomyopathy/DS01029
[5] MedlinePlus, US National Institutes of Health: http://www.nlm.nih.gov/medlineplus/ency/article/000168.htm
[6] Mayo Clinic: http://www.mayoclinic.com/health/heart-failure/DS00061
[7] Jia et al (2006). Therapeutic Potential of Endothelial Progenitor Cells for Cardiovascular Diseases.
Division of Cardiovascular Science, Department of Organ Regeneration, Shinshu University Graduate School of Medicine, Matsumoto, Japan. Current Vascular Pharmacology, 2006, 4, 59-65
[8] Assmus et al (2002). Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI).
From the Department of Molecular Cardiology and Department of Cardiology, Internal Medicine IV, (B.A., V.S., C.T., M.B., R.L., A.A., C.U.), Department of Nuclear Medicine (N.D., F.G.), and the Department of Hematology (H.M., D.H.), University of Frankfurt, Frankfurt, Germany.  American Heart Association, Circulation; 106:3009
[9] Strauer et al (2005). Regeneration of Human Infarcted Heart Muscle by Intracoronary Autologous Bone Marrow Cell Transplantation in Chronic Coronary Artery Disease.
Department of Internal Medicine, Division of Cardiology, Pneumology and Angiology; Department of Nuclear Medicine; and ‡Institute for Transplantation Diagnostics and Cell Therapeutics, Heinrich-Heine-University, Düsseldorf, Germany. Journal of the American College of Cardiology; Vol. 46, No. 9, 2005.
[10] Patel et al (2005). Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: A prospective randomized study.
Department of Cardiothoracic Surgery,a University of Pittsburgh, Pittsburgh, Pa; the Department of Cardiovascular Surgery,b Benetti Foundation, Rosario, Argentina; and the Department of Cardiothoracic Surgery,c Baylor University Medical Center, Dallas, Texas. J Thorac Cardiovasc Surg 2005;130:1631-8


Vascular

[1] Vascular Disease Foundation: http://www.vdf.org/diseaseinfo/cli/
[2] National Healing Corporation: www.nationalhealing.com/downloads/nhcwhpspring06.pdf
[3] Vascular Disease Foundation: http://www.keepingincirculation.org/articles/summer09/05.php
[4] National Institutes of Health, U.S. Department of Health and Human Services, 2009 [cited Thursday, October 28, 2010]: http://stemcells.nih.gov/info/scireport/chapter4.asp
[5] Amann et al (2009). Autologous Bone Marrow Cell Transplantation Increases Leg Perfusion and Reduces Amputations in Patients With Advanced Critical Limb Ischemia Due to Peripheral Artery Disease.
Department of Medicine, Franziskuskrankenhaus Berlin -Vascular Center, 10787 Berlin, Germany,
Cell Marker Laboratory, HELIOS Klinikum Berlin-Buch, 13122 Berlin, Germany. Cell Transplantation, Vol. 18, pp. 371–380
[6] V. Procházka et al (2009). Autologous Bone Marrow Stem Cell Transplantation in Patients with End-Stage Chronical Critical Limb Ischemia and Diabetic Foot.
Radiodiagnostic Institute University Hospital Ostrava HematoOncological Center University Hospital Ostrava; Henderson Research Center McMaster University Hamilton, Ontario, Canada, FACP Children’s Hospital,
Dana Farber Cancer Institute, Harvard MU, Boston, USA. Cell Transplantation: Manuscript Accepted Jan 2010. 
[7] Amann et al (2010). Stem cell and progenitor cell therapy in peripheral artery disease.
SRH-Klinikum Karlsbad-Langensteinbach, Angiology / Diabetology, Karlsbad, Germany; Institute for Cardiovascular Pharmacology und Epidemiology, Mahlow, Germany; Department of Internal Medicine, Franziskus Krankenhaus, Berlin Vascular Center, Berlin, Germany. Schattauer Review Article, Thrombosis and Haemostasis 103.4/2010
 

Orthopedics

[1] Mayo Clinic: http://www.mayoclinic.com/health/first-aid-fractures/FA00058
[2] American Academy of Orthopaedic Surgeons: http://orthoinfo.aaos.org/topic.cfm?topic=A00374
[3] Mayo Clinic: http://www.mayoclinic.com/health/avascular-necrosis/DS00650
[4] MedlinePlus, US National Institutes of Health: http://www.nlm.nih.gov/medlineplus/ency/article/002968.htm
[5] Mayo Clinic: http://www.mayoclinic.com/health/spinal-fusion/MY01235
[6] US National Institutes of Health: http://stemcells.nih.gov/info/scireport/chapter4.asp
[7] Hernigou et al (2005). Percutaneous Autologous Bone-Marrow Grafting for Nonunions. Surgical Technique.
Service de Chirurgie Orthopédique, Hôpital Henri Mondor, Creteil, France. JBJS Vol. 87-A, pp. 1430-1437, July 2005.
[8] Valérie Gangji et al 2004). Treatment of Osteonecrosis of the Femoral Head with Implantation of Autologous Bone-Marrow Cells.
Department of Rheumatology and Physical Medicine, Erasme University Hospital, Brussels, Belgium. JBJS Vol. 86-A, pp. 1153-1160, June 2004

 
 
 
 
Disclaimer | References